Eribulin Mesylate Intermediate 157322-47-9

Eribulin Mesylate Intermediate 157322-47-9
Product Description

3-((2S,5S)-5-((3R,5R)-3-hydroxy-6-iodo-5-methylhept-6-en-1-yl)-4-methylenetetrahydrofuran-2-yl)propyl pivalate; Any product of above involved in patent will be used for research purposes only

JIANGSU GTIG HUATAI CO.,LTD

  • CN
  • 2016
    On CPHI since
Specifications
  • CAS Registry Number
    157322-47-9

JIANGSU GTIG HUATAI CO.,LTD

  • CN
  • 2016
    On CPHI since

More Products from JIANGSU GTIG HUATAI CO.,LTD (54)

  • Alectinib Intermediate 1256584-78-7

    Product Alectinib Intermediate 1256584-78-7

    6-cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylic acid; Any product of above involved in patent will be used for research purposes only
  • Atovaquone

    Product Atovaquone

    Antimalarial, AIDS drugs;  Any product of above involved in patent will be used for research purposes only
  • Bictegravir Intermediate 1279032-31-3

    Product Bictegravir Intermediate 1279032-31-3

    Any product of above involved in patent will be used for research purposes only
  • Bictegravir Intermediate 1335210-23-5

    Product Bictegravir Intermediate 1335210-23-5

    1-(2,2-diMethoxyethyl)-5-Methoxy-6-(Methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid; Any product of above involved in patent will be used for research purposes only
  • Borate fragment of Crizotinib 877399-74-1

    Product Borate fragment of Crizotinib 877399-74-1

     Crizotinib is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) . This is a Crizotinibintermediate. 
  • Chiral intermediates of Crizotinib 877399-00-3

    Product Chiral intermediates of Crizotinib 877399-00-3

     Crizotinib is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) . This is a Crizotinibintermediate. 
  • Eribulin Mesylate Intermediate 157322-83-3

    Product Eribulin Mesylate Intermediate 157322-83-3

    methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl)oxy)-3-iodoallyl)octahydropyrano[3,2-b]pyran-2-yl)acetate;Any product of above involved in patent will be used for research purposes only
  • Eribulin Mesylate Intermediate 1808153-90-3

    Product Eribulin Mesylate Intermediate 1808153-90-3

     2-((2S,3S,4R,5R)-5-((S)-2,3-bis((tert-butyldimethylsilyl)oxy)propyl)-4-methoxy-3-(tosylmethyl)tetrahydrofuran-2-yl)acetaldehyde; Any product of above involved in patent will be used for research purposes only
  • Lumefantrine

    Product Lumefantrine

    Antimalarial drugs Any product of above involved in patent will be used for research purposes only
  • Niraparib Intermediate 875798-79-1

    Product Niraparib Intermediate 875798-79-1

    3-(4-AMINO-PHENYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;Any product of above involved in patent will be used for research purposes o
  • Obeticholic acid intermediate 459789-97-0

    Product Obeticholic acid intermediate 459789-97-0

    (R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; Any product of above involved in patent will be used for research purposes.
  • Palbociclib Intermediate 1016636-76-2

    Product Palbociclib Intermediate 1016636-76-2

    6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one; Any product of above involved in patent will be used for research purposes only